Tempo-controlled Low-load Resistance Training in Patients With Knee Osteoarthritis.

November 17, 2026 updated by: Fizza Masood, University of Management and Technology Lahore

Effects of Tempo-Controlled Low-load Resistance Training on Pain, Muscle Performance and Disability in Patients With Knee Osteoarthritis.

This randomized controlled trial aims to evaluate the effects of tempo-controlled low-load resistance training compared to conventional low-load resistance training on pain, muscle performance, and functional disability in patients with knee osteoarthritis. The study will recruit 32 participants aged 40-65 with Grade I-II knee osteoarthritis and randomly allocate them into two groups for a 6-week intervention at Ch Rehmat Ali Memorial Trust Hospital. Group A will perform strengthening exercises (such as sit-to-stand, mini squats, and leg raises) using a controlled 3-1-3 second tempo cadence (eccentric, isometric hold, concentric), while Group B will perform the same exercises at a self-selected speed; both groups will receive preparatory moist heat, warm-ups, knee isometrics, and Maitland mobilizations three times weekly. Primary outcomes-including pain intensity (NPRS), functional difficulty (WOMAC), walking endurance (6MWT), and mobility (TUG)-will be evaluated at baseline and 6 weeks to determine if tempo control offers a more effective, well-tolerated alternative for managing knee osteoarthritis.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • UMT
        • Contact:
        • Contact:
          • Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT
          • Phone Number: +923434570838
          • Email: rabia.jawa@umt.edu.pk
        • Sub-Investigator:
          • Omaima Rahim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients diagnosed with knee osteoarthritis according to clinical criteria.
  • Age between 40-65 years.
  • Both male and female participants.
  • NPRS pain score between >3/10 and 6/10.
  • Radiographic grade I-II knee osteoarthritis.
  • Ability to walk independently without assistive device.

Exclusion Criteria:

  • Recent knee surgery within the last six months.
  • Inflammatory joint diseases such as rheumatoid arthritis.
  • Severe diagnosed cardiovascular or neurological disorders.
  • Intra-articular injections within previous three months.
  • Uncontrolled hypertension or diabetes.
  • Severe diagnosed knee deformities requiring surgical intervention.
  • Cognitive impairment (Parkinson) affecting exercise participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tempo-controlled low load resistance training

Participants will receive a 10-minute moist heat application, followed by a 5-10-minute warm-up, knee isometric exercises, and Maitland mobilization. The intervention will include sit-to-stand, mini squats, straight leg raises, step-ups, terminal knee extensions, and seated knee extensions. Each exercise will be performed at a controlled tempo of 3 seconds eccentric, 1-second isometric hold, and 3 seconds concentric, with 3 sets of 10 repetitions and 1-minute rest intervals between sets. Exercise progression will be individualized according to patient tolerance.

The intervention will include sit-to-stand, mini squats, straight leg raises, step-ups, terminal knee extensions, and seated knee extensions. Each exercise will be performed at a controlled tempo of 3 seconds eccentric, 1-second isometric hold, and 3 seconds concentric, with 3 sets of 10 repetitions and 1-minute rest intervals between sets. will receive treatment three times per week for six weeks.

Active Comparator: Conventional Physiotherapy Training

Participants will receive the same initial physiotherapy treatment and strengthening exercises as Group A, but the exercises will be performed at a self-selected speed without tempo control. Each exercise will consist of 3 sets of 10 repetitions. Both groups will receive treatment three times per week for six weeks.

Participants will receive the same initial physiotherapy treatment and strengthening exercises as Group A, but the exercises will be performed at a self-selected speed without tempo control. Each exercise will consist of 3 sets of 10 repetitions and will receive treatment three times per week for six weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline and after 6 weeks

The Numeric Pain Rating Scale (NPRS) is an 11-point numerical scale used to assess pain intensity. Scores range from 0, indicating no pain, to 10, representing the worst imaginable pain. Participants rate their perceived knee pain, and changes in scores are used to evaluate the effectiveness of the interventions in reducing pain intensity.

Baseline and after 6 weeks
WOMAC Function Subscale
Time Frame: Baseline and after 6 weeks

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscale is a disease-specific questionnaire used to assess physical disability in patients with knee osteoarthritis. It evaluates the degree of difficulty experienced during daily activities, including stair climbing, sitting, standing, walking, and household tasks. Changes in scores indicate improvements or worsening in functional ability.

Baseline and after 6 weeks
Six-Minute Walk Test (6MWT)
Time Frame: Baseline and after 6 weeks

The Six-Minute Walk Test is a functional performance test used to assess walking endurance and functional exercise capacity. Participants are instructed to walk as far as possible for six minutes, and the total distance covered is recorded in meters. An increase in walking distance indicates improved functional exercise capacity and mobility.

Baseline and after 6 weeks
Timed Up and Go (TUG) Test
Time Frame: Baseline and after 6 weeks

The Timed Up and Go Test is a clinical assessment tool used to measure functional mobility and dynamic balance. Participants are instructed to rise from a chair, walk three meters, turn around, return to the chair, and sit down. The total time required to complete the task is recorded in seconds. A reduction in completion time generally indicates improved functional mobility and movement performance.

Baseline and after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 27, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 26, 2026

First Submitted That Met QC Criteria

October 26, 2026

First Posted (Actual)

November 2, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 17, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The results data collected , de-identified individual participant data will be shared.

IPD Sharing Time Frame

6 months after the publication of the manuscript.

IPD Sharing Access Criteria

The data can be requested from the corresponding author

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe